Clinical Trials Browser

Phase 2 × Suspended × Alemtuzumab × Clear all

NCT01982175 2022-06-21

CLL004

Phase 2 Suspended

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell